Skip to contentB
biote Corp.
B
BTMDbiote Corp. Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$49.83M$49.83Mderived+9.0% vs Q4 2023 Net Income$3.70M$3.70Mderived−52.1% vs Q4 2023 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
biote Corp. · CIK 1819253 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived$2,767,000−49.8% Operating Cash Flowderived$12,368,000+77.8% Free Cash Flowderived$10,698,000+50.4% Margins · derivedOperating margin5.6%−6.5 pt vs Q4 2023
Net margin7.4%−9.5 pt vs Q4 2023
ended Dec 31, 2024 · filed Mar 14, 2025 · 73 d after period end